April 17, 2025
HIMS Stock: Poised for a Comeback After Dropping Below $30?
Hims & Hers Health Faces Market Challenges but Shows Growth Potential Hims & Hers Health (NYSE: HIMS), a telehealth platform, has experienced significant stock declines, with prices falling 60% from February peaks above $70 to currently below $30. Long-term investors may be familiar with this trend, as HIMS has seen steep drops previously—most notably an 87% decline during the inflation surge in 2022 and a 77% drop in 2020. In response to shortages of popular weight loss drugs from Eli Lilly and Novo Nordisk, HIMS adapted by offering compounded substitutes. With these shortages easing, the company has now shifted its